For the Love of Continuous!
Sitting Down With… Bernhardt Trout, Raymond F. Baddour, ScD, (1949) Professor of Chemical Engineering, Director, Novartis-MIT Center for Continuous Manufacturing
Maryam Mahdi | | Interview
This article was published in our sister publication, The Small Molecule Manufacturer, which celebrates the field of small molecule drug development and manufacturing with interviews and articles focusing on success stories, equipment, and new processing techniques. Read more about The Small Molecule Manufacturer here https://themedicinemaker.com/manufacture/small-but-never-forgotten
How did the Novartis-MIT Center for Continuous Manufacturing come to be?
The center’s journey began in the early 2000s. Novartis had an interest in continuous manufacturing practices and had been working in collaboration with MIT to help facilitate a transition away from traditional batch manufacturing processes. The Swiss multinational pledged $65 million to MIT to pursue research into what was, at the time, a really novel method of producing drugs.
I had been involved in some of the early talks with the Novartis’ head of manufacturing, and the conversations we had helped dictate the aims of the 10-year partnership that was formed. Everything came together in the mid-2000s, as a team was formed to assess the benefits of collaborating on continuous manufacturing for the wider industry.
Read the full article now
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.